On the tissue repair side, BPC-157 upregulates growth hormone receptors on tendon fibroblasts, promotes blood vessel formation through the VEGFR2-Akt-eNOS pathway, and activates the FAK-paxillin pathway for fibroblast migration
Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage
Reconstituted BPC-157 lasts 28 days refrigerated
Duration of Results Skin tone improvements may last several weeks or months after completing a treatment course
Jo KW, Lee D, Cha DG, Oh E, Choi YH, Kim S, et al
Very sweet staff and very professional